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Abstract
Background: Recently, excellent results are reported on laparoscopic lavage in patients with purulent perforated
diverticulitis as an alternative for sigmoidectomy and ostomy.
The objective of this study is to determine whether LaparOscopic LAvage and drainage is a safe and effective treatment
for patients with purulent peritonitis (LOLA-arm) and to determine the optimal resectional strategy in patients with a
purulent or faecal peritonitis (DIVA-arm: perforated DIVerticulitis: sigmoidresection with or without Anastomosis).
Methods/Design: In this multicentre randomised trial all patients with perforated diverticulitis are included. Upon
laparoscopy, patients with purulent peritonitis are treated with laparoscopic lavage and drainage, Hartmann’s
procedure or sigmoidectomy with primary anastomosis in a ratio of 2:1:1 (LOLA-arm). Patients with faecal
peritonitis will be randomised 1:1 between Hartmann’s procedure and resection with primary anastomosis (DIVA-
arm). The primary combined endpoint of the LOLA-arm is major morbidity and mortality. A sample size of
132:66:66 patients will be able to detect a difference in the primary endpoint from 25% in resectional groups
compared to 10% in the laparoscopic lavage group (two sided alpha = 5%, power = 90%). Endpoint of the DIVA-
arm is stoma free survival one year after initial surgery. In this arm 212 patients are needed to significantly
demonstrate a difference of 30% (log rank test two sided alpha = 5% and power = 90%) in favour of the patients
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any medium, provided the original work is properly cited.with resection with primary anastomosis. Secondary endpoints for both arms are the number of days alive and
outside the hospital, health related quality of life, health care utilisation and associated costs.
Discussion: The Ladies trial is a nationwide multicentre randomised trial on perforated diverticulitis that will
provide evidence on the merits of laparoscopic lavage and drainage for purulent generalised peritonitis and on the
optimal resectional strategy for both purulent and faecal generalised peritonitis.
Trial registration: Nederlands Trial Register NTR2037
Background
Diverticular disease is an important condition in terms
of healthcare utilisation andi ti so n eo ft h ef i v em o s t
costly gastrointestinal disorders in westernised countries
[1]. Despite this high prevalence, treatment of all differ-
ent stages of diverticular disease is still hardly evidence
based, hence containing a lot of controversies.
Perforated diverticulitis is a perforation of an inflamed
diverticulum of the large bowel, mostly the sigmoid,
resulting in either purulent or faecal peritonitis (Hinchey
stadia III or IV). Both conditions require emergency sur-
gery[2,3]. Regardless of selected strategy emergency
operations for acute perforated diverticulitis are asso-
ciated with substantial morbidity (up to 50%) and mor-
tality (15 to 25%)[3-8]. Primary sigmoidectomy with or
without anastomosis has become the standard practice
for patients with generalised peritonitis complicating
diverticulitis [6-10] and for many surgeons the
Hartmann’s procedure remains the favoured option.
Restoration of bowel continuity after this procedure is a
technically difficult operation, with high morbidity and
mortality rates[11,12]. Therefore stoma reversal after HP
is only performed in 50 to 60% of the patients, thereby
compromising quality of life and increasing costs[13,14].
Recently laparoscopic lavage (LL) emerged as an effec-
tive alternative for patients with perforated diverticulitis
with purulent peritonitis[15]. This nonresectional proce-
dure has first been described by O’Sullivan in 1996[16].
In 2009, a systematic review on all studies on laparo-
scopic lavage with a total number of 231 patients was
performed. Mortality was less than 2% and a (permanent)
colostoma was avoided in the majority of these patients
[15-22]. So laparoscopic lavage for perforated purulent
diverticulitis has a great potential in improving health
and reducing costs.
Nevertheless, since sigmoidectomy is still considered
the standard of care for perforated diverticulitis, imple-
mentation of LL might be variable. Some surgeons will
embrace lavage because of its technical simplicity; other
might be reluctant fearing failure of this novel strategy.
Only a head to head comparison of both surgical strate-
gies will provide an evidence based surgical approach of
patients with perforated diverticulitis with purulent peri-
tonitis (LOLA-arm).
In case of faecal peritonitis there is no evidence that
LL is a valid alternative for a resectional strategy. But
again, the optimal surgical treatment is still a matter of
debate. The available literature suggests equality of
Hartmann’s procedure (HP) and resection with primary
anastomosis (PA) regarding postoperative mortality and
morbidity[5,8,9,23,24]. The likelihood of stoma closure
seems higher after PA with ileostomy (85%) compared
to HP (60%), but robust evidence is lacking [13,25].
Therefore, HP and PA are compared to determine the
optimal resectional treatment for perforated diverticulitis
with generalised purulent or faecal peritonitis, regarding
stoma free survival (DIVA-arm).
Study objectives
For this two-armed randomised trial two objectives can
be defined to determine the optimal strategy for the
treatment of perforated diverticulitis. First, is laparo-
scopic lavage for patients with purulent peritonitis
superior compared to sigmoidectomy, in terms of mor-
tality, morbidity, quality of life, health care utilisation
and associated costs (LOLA-arm)? Secondly, is HP or
PA the superior approach for patients with purulent or
faecal generalised peritonitis in terms of stoma free sur-
vival, quality of life and cost-effectiveness (DIVA-arm)?
Methods/Design
The Ladies trial is designed as a nationwide multicentre
randomised trial in which patients with generalised peri-
tonitis caused by perforated diverticulitis are randomised
to undergo either laparoscopic lavage and drainage or
resectional surgery by laparotomy.
Patients presenting with clinical signs of diverticulitis
with diffuse peritonitis can be included upon the finding
of free gas on plain abdominal radiography, upon the
finding of free gas on CT, or upon the finding of perito-
nitis with diffuse fluid or gas on CT. Exclusion criteria
include dementia, pelvic irradiation, steroid treatment,
prior sigmoidectomy and preoperative shock with ino-
tropic requirement. All patients need to fulfil the selec-
tion criteria and will need to give written informed
consent.
Eligible patients undergo diagnostic laparoscopy to
exclude other causes of generalised peritonitis. If the
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patient can be enrolled and randomised. Block-randomi-
sation is performed during laparoscopy via the trial web-
site according to Figure 1.
In case of purulent peritonitis (Hinchey III) patients
are randomised to LL, HP or PA (LOLA-arm). The best
evidence indicates that the latter two resectional strate-
gies are equal in terms of postoperative morbidity and
mortality in case of generalised peritonitis[8]. For this
reason a three way 2:1:1 randomisation is performed. In
case of an overt perforation with faecal peritonitis
(Hinchey IV) patients will undergo laparotomy and are
randomised 1:1 to either undergo HP or PA.
Patients who are either ineligible for trial entry, who
show other causes of peritonitis than diverticulitis at
laparoscopy or who do not wish to take part in the
study are treated at the discretion of the surgeon on
call. These patients will be registrated by the trial
coordinator.
Endpoints
Primary endpoint of the LOLA-arm is the combined
number of mortality and major morbidity, twelve
months after initial surgery. Secondary endpoints of the
LOLA-arm are quality of life, health care utilisation and
associated costs. Mayor morbidity includes reinterven-
tion, fascial dehiscence, incisional hernia, myocardial
infarction, urosepsis, respiratory failure and renal failure.
Respiratory failure is defined as a SOFA score of less
than 300. Renal failure is defined as a threefold creati-
nine increase or a GFR decrease over 75% or a urinary
output of less than 0.3/kg/h for 24 hours or anuria for
twelve hours.
Primary endpoint of the DIVA-arm is the stoma free
survival within twelve months after initial surgery. Second-
ary endpoints are quality of life and cost-effectiveness.
Participating centres
More than thirty-five teaching hospitals in the Nether-
lands are participating in this trial, including six aca-
demic centres.
Study population
This study consists of patients eligible for surgical treat-
ment of perforated diverticulitis. Inclusion criteria are
age between 18 and 85 years, a clinical suspicion for
perforated diverticulitis and free gas on plain abdominal
radiography, free gas on CT, or peritonitis with diffuse
fluid or gas on CT.
Ethics
This study will be conducted in accordance with the
principles of the Declaration of Helsinki and Good Clin-
ical Practice guidelines. Medical ethics approval has
been obtained by the medical ethics committee from the
Academic Medical Centre in Amsterdam, dated
Figure 1 Study profile.
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informed consent must be obtained from all patients.
Study outline
Diagnostic laparoscopy: a careful inspection of the sto-
mach, duodenum and sigmoid is performed to localise
the site of perforation. In case of peritonitis due to a per-
forated diverticulum it must be attempted gently to
locate the site of perforation. Careful removal of adherent
omentum or bowel is tried. If clearly adherent, it should
be left in place.
If no obvious perforation is apparent and faecal con-
tent is absent, the patient is randomised online between
treatment with LL, HP or PA in a ratio 2:1:1.
In case of an overt perforation or intra-abdominal
contamination with faeces, the patient is not eligible for
LL and is randomised between HP and PA.
LL: the abdominal cavity is irrigated with six litres of
w a r ms a l i n e .A tt h ee n do ft h ep r o c e d u r eaD o u g l a s
drain is inserted via the right lateral port.
HP: The perforated diseased part must be resected.
There is no need of having the distal transsection line
on the proximal rectum. An end-colostomy is per-
formed according to the preference of the operating sur-
geon, the same accounts for closing the rectal stump.
PA: Sigmoidectomy is done according to the guide-
lines of the American Society of Colon and Rectal Sur-
geons[26,27]. The distal transsection margin has to be
on the proximal rectum, the proximal margin is deter-
mined by the absence of wall thickening due to diverti-
culitis. The type of anastomosis and the decision to
perform a defunctioning loop-ileostomy are to the dis-
cretion of the surgeon on call.
Leaving a Douglas drain after resectional surgery is at
the discretion of the operating surgeon. The resected
tissue is sent for histological investigation to exclude
malignancy.
Antibiotics are administered for seven days in both
groups. Postoperatively, oral diet and mobilisation are
advanced as soon as possible. Within four to six weeks
after surgery a sigmoidoscopy is performed to exclude
malignancy as the underlying cause of the perforation.
After the sigmoidoscopy is performed, the patient will
be offered reversal of the stoma, when he or she is found
eligible for surgery by the surgeon and anaesthesiologist.
Statistical analysis
The analysis will be performed in accordance with the
intention to treat principle.
In the LOLA-arm of the study, the assumpted differ-
ence in the combined number of mortality and major
morbidity between laparoscopic lavage and resection is
15%. With a two sided likelihood ratio test and a signifi-
cance level of 0.05, a sample size of 132:66:66 will be
necessary to detect this difference. With a group size of
a hundred patients per arm it is also possible to find a
significant difference (alpha = 0.05, beta = 0.1) of at
least 10% in subscales of the SF-36, a validated quality
of life questionnaire, at two, four, thirteen, 26 and
52 weeks after initial surgery.
In the DIVA-arm 212 patients are needed to signifi-
cantly demonstrate a difference in stoma free survival
between both treatment arms, using log rank statistics
with a power of 90% and a type I error of 5%. The sus-
pected postoperative mortality for HP and PA is equally
high (+ 15%)[8]. About 60% of the patients that under-
went HP have their stoma reversed[11,12]. When cor-
rected for the expected mortality before reversal, the
reversal rate will be 50%. Patients with a protective
loop-ileostomy after PA will have their enterostomy
reversed in over 85%[12]. After correction for expected
mortality before reversal, this will result in a 72% stoma
reversal rate in the initial patient population.
Economic evaluation
Comparisons of the different surgical strategies in the
economic evaluation will be analogous to the analyses of
the clinical endpoints. The economic evaluation will be
performed from a societal perspective, with the costs
per unit improvement on the primary clinical endpoints,
defined as combined mortality and morbidity for the
LOLA-arm, and stoma free survival for the DIVA-arm.
We hypothesise that a more effective intervention will
be associated with less health care utilisation as well as
absence from paid work (productivity costs). Therefore,
the primary analysis will be a cost-effectiveness analysis
that evaluates costs associated with an improved surgical
outcome.
In addition, a secondary analysis will evaluate cost dif-
ferences in relation to differences in quality-adjusted
life-years (QALYs). This cost-utility analysis, resulting in
an incremental cost-effectiveness ratio expressed in
costs per QALY, will be included to allow comparison
with other health-related interventions or programs.
With a study horizon of twelve months, no discounting
will be applied. We will differentiate between direct
medical, direct non-medical and indirect costs.
Data collection and monitoring
An electronic Case Report Form (CRF) will include gen-
eral patients data: sex, age, medical history, POSSUM-
score, preoperative APACHE-score, surgical parameters,
Hinchey score, data concerning type of intervention, com-
plications, mortality, duration of hospital and intensive
care stay and the patients response to the questionnaires.
Patients will be followed for a period of twelve
months. During this follow-up period patients will com-
plete a set of questionnaires (SF-36, EQ-5D and GIQLI)
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gery. The questionnaires will be sent to the patients by
mail accompanied by a stamped return envelope. Collec-
tion of the questionnaires will be safeguarded by the
trial coordinator.
At four, thirteen, 26, 39 and 52 weeks after initial sur-
gery, the patients will be asked to complete question-
naires to assess complications, additional interventions,
readmissions, duration of hospital and intensive care
stay, visits to the outpatient clinic, number of days of sick
leave and to ensure completions of the questionnaires.
Patient safety
An independent data monitoring and safety committee
has been established to interpret the data from the cur-
rent trial, to monitor any early significant differences
between the groups of treatment and to make interim
analyses to decide on continuation of the study after
every 25 included patients.
An independent trial monitor will monitor the study
procedure and the data of included patients.
A data management agency created the online data-
base of the study to guard the entry of data by the local
investigators. The same organisation has trained all trial
coordinators, all local investigators and some local co-
investigators on the guidelines of Good Clinical Practice.
The trial coordinators have trained all other personnel
on the protocol, on asking informed consent, on report-
ing Serious Adverse Events and on data entry.
According to the Good Clinical Practice guidelines, a list
of Serious Adverse Events is defined. All events on this list
have to be reported by the local investigators to the trial
coordinators within 24 hours after the event. These events
will be reported to the central Medical Ethics Committee
(CCMO) within 24 hours afterwards. With this measure,
the central Medical Ethics Committee compares the inci-
dence of complications between the arms of the trial and
can decide on continuation of the trial.
Discussion
Since the introduction of laparoscopic lavage and drai-
nage for purulent peritonitis for perforated diverticulitis
in 1996, the number of patients treated with this new
method had gradually inclined. However, there have
been no publications of high methodological quality on
this topic[28]. Therefore we do not know whether
laparoscopic lavage is in fact a safe and effective treat-
ment. Since the existing publications do promise a sig-
nificant reduction in mortality and major morbidity, a
randomised trial is appropriately warranted. A data
monitoring committee will guard the methodological
quality of the study, the safety of the patients, and moni-
tor any early significant differences between the different
surgical strategies.
We have not found any evidence that laparoscopic
lavage is a safe treatment for perforated faecal peritoni-
tis. Therefore in this group of patients randomisation
will only take place between the two resectional
strategies.
In the presented study all patients suspected for perfo-
rated diverticulitis are included, and a midline laparot-
omy can be avoided in selected patients with other
pathology.
We do not know whether the lavage itself is impor-
tant for the treatment of the peritonitis, since there are
no publications on the treatment of purulent perfo-
rated diverticulitis with diagnostic laparoscopy and
antibiotic treatment alone. Laparoscopic lavage in
combination with antibiotic treatment however, has
been examined in a systematic review with very pro-
mising results[28].
The stoma reversal rate is the primary endpoint for the
DIVA-arm of the trial. Questions could be raised about
the benefits of this reversal for a patient that is inconti-
nent for faeces. A definitive colostoma for this specific
group of patients might be preferable considering daily
care. However this group of patients will be small and no
studies have compared quality of life for incontinent
patients with or without a stoma. The colostoma and
ileostoma show equal impact on the patients quality of
life, [29] and quantification of incontinence problems is
unpractical in the emergency setting. Therefore inconti-
nence is not established as an exclusion criterion. All
resections will be performed with the intention of stoma
reversal.
In the Netherlands the standard of care for perforated
diverticulitis is either HP or PA. Resection with primary
anastomosis is a type of treatment not mastered by
every gastrointestinal surgeon. In the emergency setting,
some surgeons might prefer HP, fearing anastomotic
leakage. However, there is no clear evidence available
showing a difference in mortality and major morbidity
between HP and PA. Therefore we decided to include
treatment with PA in the randomisation process of the
LOLA-arm as well.
Our hypothesis is that PA leads to a 22% higher stoma
free survival, and that this procedure might be advo-
cated as the new standard of care in selected patients
with generalised peritonitis caused by perforated
diverticulitis.
List of abbreviations
LOLA-arm: Laparoscopic lavage and drainage or sigmoidectomy with HP or
PA for purulent peritonitis for perforated diverticulitis; DIVA-arm:
Sigmoidectomy with HP or PA for generalised peritonitis for perforated
diverticulitis; SF-36: Quality of Life Questionnaire Short Form 36; GIQLI: Gastro
Intestinal Quality of Life Index; EQ-5D: Euro Quality of Life Questionnaire; LL:
Laparoscopic lavage; HP: Hartmann’s procedure; PA: Sigmoidectomy with
primary anastomosis.
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